Status:
WITHDRAWN
Impact of the ProbeFix on the Workflow of Pharmacological Stress Echocardiography Examinations
Lead Sponsor:
Amir Abbas Mahabadi
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pharmacological stress-echocardiography examinations are routinely performed in daily clinical practice. Usually, the echo probe is manually placed on the patient's thorax by the physician. The ProbeF...
Eligibility Criteria
Inclusion
- Patients undergoing clinically indicated pharmacological stress-echocardiography
- Willingness to participate
Exclusion
- Pharmacological stress echocardiography indication other than evaluation of stress induced ischemia (e.g. Low-Flow-Low-Gradient aortic valve stenoseis)
- poor image quality
- Early termination of the stress-echocardiography examination for clinical reasons
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04016363
Start Date
January 1 2020
End Date
December 31 2020
Last Update
October 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Essen
Essen, North Rhine-Westphalia, Germany, 45147